Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444092 · ClinicalTrials.gov registry record · Phase 3
Safety Study of Entocort for Children With Crohn's Disease
A Phase 3 study, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 123
- Enrollment target
NCT01444092 is a Phase 3 study that has completed, run by Padagis. The registered enrollment target is 123 participants.
The verdict
NCT01444092, a Phase 3 study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 123 participants
- Enrollment target
Study Summary
A Safety Study using Entocort EC for children with mild to moderate Crohn's Disease
Interventions
- DRUG Entocort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01444092
The ClinicalTrials.gov registry entry for NCT01444092 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Padagis, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Entocort is the first listed.
NCT01444092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01444092 about?
NCT01444092 is a clinical study titled "Safety Study of Entocort for Children With Crohn's Disease". A Safety Study using Entocort EC for children with mild to moderate Crohn's Disease
What is the current status of trial NCT01444092?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 123 participants. The study started on 2011-11. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01444092?
The interventions under investigation include: Entocort (DRUG).
Who is sponsoring clinical trial NCT01444092?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.